Throughout 2023 we have listened closely to our partners, healthcare providers, clinicians and patient stakeholders responding to their needs with our ongoing investments in talented people and product development. We are delighted to have seen this succeed with the expansion of our partnerships and the brilliant response from clinicians and patients to our technology. Here …
According to the 2020 ESC Atrial Fibrillation (AF) Guidelines it’s clear that the high prevalence of asymptomatic AF shows a growing need of clinically validated mobile screening tools, as it is “associated with increased risk of stroke and mortality compared with symptomatic AF. The ESC Guideline suggests caution because “>100 000 mHealth (mobile Health) …
The Dutch Cardiologists Association Recommends Happitech’s CE-certified Technology Read More »
According to the 2020 ESC Atrial Fibrillation (AF) Guidelines it’s clear that the high prevalence of asymptomatic AF shows a growing need of clinically validated mobile screening tools, as it is “associated with increased risk of stroke and mortality compared with symptomatic AF. The ESC Guideline suggests caution because “>100 000 mHealth (mobile Health) …
Happitech Was Selected For The Kickstart Innovation Program Read More »
